|
GB201212604D0
|
|
New treatment
|
|
EP2498779A1
|
|
Pemirolast for the treatment of systemic low grade inflammation
|
|
ZA200904249B
|
|
New combination for use in the treatment of inflammatory disorders
|
|
WO2009122182A1
|
|
New combination for use in the treatment of inflammatory disorders
|
|
EP2303251A1
|
|
New combination for use in the treatment of inflammatory disorders
|
|
WO2009122181A1
|
|
New combination for use in the treatment of inflammatory disorders
|
|
WO2009122183A1
|
|
New combination for use in the treatment of inflammatory disorders
|
|
WO2009007674A2
|
|
Combination for use in the treatment of atherosclerosis comprising a mast cell inhibitor and ramatroban or seratrodast
|
|
WO2009007679A2
|
|
Combination for use in the treatment of atherosclerosis comprising a mast cell inhibitor and a thromboxane a2 antagonist
|
|
WO2009007673A2
|
|
Combination for use in the treatment of atherosclerosis comprising a mast cell inhibitor and a ppar gamma agonist
|
|
WO2009007675A2
|
|
Combination for use in the treatment of atherosclerosis comprising a mast cell inhibitor and a p2 gamma 12 antagonist
|
|
WO2009007680A2
|
|
Combinations comprising a mast cell inhibitor and a statin for use in the treatment of inflammatory disorders
|
|
EP2129368A1
|
|
Combination for use in the treatment of inflammatory disorders
|
|
WO2008087371A1
|
|
New combination for use in the treatment of inflammatory disorders
|
|
EP2107907A1
|
|
Combination of pemirolast and ramatroban for use in the treatment of inflammatory disorders
|
|
BRPI0720358A2
|
|
Combined product, parts kit, use of a combined product and methods of producing a parts kit and treating inflammatory disturbance.
|
